Skip to content
Main Navigation
Aveo Oncology Logo
  • About
  • Partnerships
  • Our Science
  • Medical Information
  • Newsroom
  • Contact
    • About
      • Culture
      • Management Team
      • Careers
      • Compliance and Ethics
      Partnerships
      • Scientific Advisory Committee
      Our Science
      • FOTIVDA
      • Ficlatuzumab
      • AV-380
      • Patents
      Medical Information
      • Publications & Presentations
      • Medical Grants – IST
      • Medical Grants – CME
      • Expanded Access Policy
      Newsroom
      Contact
  • About
    • Culture
    • Management Team
    • Careers
    • Compliance and Ethics
  • Partnerships
    • Scientific Advisory Committee
  • Our Science
    • FOTIVDA
    • Ficlatuzumab
    • AV-380
    • Patents
  • Medical Information
    • Publications & Presentations
    • Medical Grants – IST
    • Medical Grants – CME
    • Expanded Access Policy
  • Newsroom
  • Contact

Category: Publication

GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling

Posted on September 29, 2010 (May 31, 2024) by michael

Authors: Ailin Bai, Kristan Meetze, Nhi Y. Vo, Sriram Kollipara, Elizabeth K. Mazsa, William M. Winston, Solly Weiler, Laura L. Poling, Ting Chen, Nesreen S. Ismail, Jinwei Jiang, Lorena Lerner, Jeno Gyuris, Zhigang Weng. Click here for link to article.

Posted in Publication

Posts navigation

  • «
  • 1
  • 2
  • 3
  • Careers
  • Terms of Use
  • Privacy Policy
  • LG Chem
  • Code of Business Conduct and Ethics